Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-03-20 4:17 pm Unchanged | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | ARMISTICE CAPITAL LLC | 1,419,507 19.6% | 0 (Unchanged) | View |
2020-03-19 5:18 pm Purchase | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 39,563,762 58.3% | 1,981,219 (+5.27%) | View |
2020-03-16 5:23 pm Sale | 13D | CERECOR INC CERC | ARMISTICE CAPITAL LLC | 37,582,543 55.4% | -3,042,687 (-7.49%) | View |
2020-03-16 4:44 pm Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIV | ARMISTICE CAPITAL LLC | 111,376 4.99% | 111,376 (New Position) | View |
2020-03-16 4:37 pm Purchase | 13G | SENESTECH INC PAR $0.0 SNES | ARMISTICE CAPITAL LLC | 92,884 4.99% | 92,884 (New Position) | View |
2020-03-16 4:21 pm Purchase | 13G | ZOSANO PHARMA CORP ZSAN | ARMISTICE CAPITAL LLC | 2,853,921 4.99% | 948,256 (+49.76%) | View |
2020-03-13 4:57 pm Sale | 13D | AYTU BIOSCIENCE INC AYTU | ARMISTICE CAPITAL LLC | 5,000,001 9.1% | -7,362,139 (-59.55%) | View |
2020-03-13 4:36 pm Unchanged | 13G | AIKIDO PHARMA INC AIKI | ARMISTICE CAPITAL LLC | 0 0% | 0 (Unchanged) | View |
2020-03-12 5:13 pm Purchase | 13G | SUPERNUS PHARMACEUTICALS INC C SUPN | ARMISTICE CAPITAL LLC | 2,888,000 5.5% | 2,888,000 (New Position) | View |
2020-03-06 4:59 pm Purchase | 13G | MALLINCKRODT PUB LTD CO SHS MNK | ARMISTICE CAPITAL LLC | 5,680,000 6.7% | 1,500,000 (+35.89%) | View |
2020-03-06 4:56 pm Purchase | 13G | NOVAN INC NOVN | ARMISTICE CAPITAL LLC | 2,548,209 4.99% | 2,548,209 (New Position) | View |
2020-03-05 5:24 pm Purchase | 13G | VOYAGER THERAPEUTICS INC VYGR | ARMISTICE CAPITAL LLC | 2,000,000 5.4% | 376,000 (+23.15%) | View |
2020-03-05 5:15 pm Purchase | 13G | OUTLOOK THERAPEUTICS INC N OTLK | ARMISTICE CAPITAL LLC | 2,685,273 4.99% | 2,685,273 (New Position) | View |
2020-02-28 5:18 pm Purchase | 13G | AETERNA ZENTARIS INC AEZS | ARMISTICE CAPITAL LLC | 1,213,738 5.2% | 191,491 (+18.73%) | View |
2020-02-21 4:38 pm Purchase | 13G | ZOSANO PHARMA CORP ZSAN | ARMISTICE CAPITAL LLC | 1,905,665 4.99% | 1,905,665 (New Position) | View |
2020-02-21 4:29 pm Purchase | 13G | ZOMEDICA CORP COM ZOM | ARMISTICE CAPITAL LLC | 6,768,444 4.99% | 6,768,444 (New Position) | View |
2020-02-20 4:24 pm Purchase | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | ARMISTICE CAPITAL LLC | 390,720 4.99% | 390,720 (New Position) | View |
2020-02-20 2:49 pm Sale | 13D | INNOVUS PHARMACEUTICALS, INC. INNV | ARMISTICE CAPITAL LLC | 0 0% | -300,000 (Position Closed) | View |
2020-02-20 2:43 pm Purchase | 13D | AYTU BIOSCIENCE INC AYTU | ARMISTICE CAPITAL LLC | 12,362,140 40% | 3,983,448 (+47.54%) | View |
2020-02-14 3:42 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | ARMISTICE CAPITAL LLC | 1,750,000 3.4% | 1,750,000 (New Position) | View |